Erratum: Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease (Blood Advances (2017) 1:20 (1645-1649) DOI: 10.1182/bloodadvances.2017009613)

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Erratum: Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease (Blood Advances (2017) 1:20 (1645-1649) DOI: 10.1182/bloodadvances.2017009613)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Nursing and Health Professions

Medicine and Dentistry